SCHIERMEIER ANDREW 4
4 · Intellia Therapeutics, Inc. · Filed Jan 4, 2021
Insider Transaction Report
Form 4
SCHIERMEIER ANDREW
EVP, Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2020-12-30$13.48/sh+1,500$20,220→ 12,673 total - Exercise/Conversion
Stock Option (right to buy)
[F2]2020-12-30−1,500→ 148,500 totalExercise: $13.48Exp: 2027-01-02→ Common Stock (1,500 underlying)
Footnotes (2)
- [F1]Includes 857 shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2020.
- [F2]The stock option award was issued pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan and had vested as to 146,875 shares as of December 30, 2020.
Signature
/s/Jose Rivera, Attorney-In-Fact|2021-01-04